OverviewSuggest Edit
Novartis researches, develops, manufactures, and markets a range of healthcare products. The Innovative Medicines segment offers patented prescription medicines, commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, and respiratory. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as contact lenses and contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers.
| Type | Public | |
| Founded | 1996 | |
| HQ | Basel, CH | Map |
| Website | novartis.com | |
| Employee Ratings | More |
Recent NewsAll News
- Global Eye Infections Treatment Market Size & Positive Long-Term Growth Outlook 2019-2025 : Allergan Inc., Alcon Laboratories Inc., Johnson & Johnson Ltd., Pfizer Inc., Merck & Co., Inc., Novartis
- Cell and Gene Therapy Market – Major Technology Giants in Buzz Again | Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis
- Biosimilar Drugs Market Growth & Key Business Strategies by Leading Industry Players Novartis, Celltrion, Biocon, Hospira, Merck Serono, Biogen idec, Genentech
- Trending Report on Systemic Hypertension Market 2019: By Top Leading Players like Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim, Sanofi, and Pfizer
Key People/Management at Novartis
Vasant Narasimhan
Steven Baert
Bertrand Bodson
James Bradner
Richard Francis
Paul Hudson
Novartis Office Locations
Novartis Financials and Metrics
Novartis Revenue
| USD | |
|---|---|
Revenue (FY, 2017) | 49.1b |
Revenue growth (FY, 2016 - FY, 2017), % | 1.2% |
Gross profit (FY, 2017) | 31.9b |
Gross profit margin (FY, 2017), % | 65% |
Net income (FY, 2017) | 7.7b |
Cash (31-Dec-2017) | 8.9b |
- Source: Company Filings
| USD | FY, 2016 | FY, 2017 |
|---|---|---|
Cash | 7.0b | 8.9b |
Accounts Receivable | 8.2b | 8.6b |
Inventories | 6.3b | 6.9b |
Current Assets | 24.9b | 28.2b |
| USD | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|
Net Income | 7.0b | 6.7b | 7.7b |
Cash From Operating Activities | 11.9b | 11.5b | 12.6b |
Purchases of PP&E | (2.4b) | (1.9b) | (1.7b) |
Cash From Investing Activities | (10.8b) | (3.4b) | (3.1b) |
| USD | Y, 2017 |
|---|---|
Revenue/Employee | 405.5k |
Financial Leverage | 1.8 x |
Novartis Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Advanced Accelerator Applications | October 30, 2017 | $3.90 b |
| AveXis | $8.70 b |
Novartis Revenue Breakdown
Novartis revenue breakdown by business segment: 12.3% from Alcon, 20.5% from Sandoz and 67.2% from Innovative Medicines
Novartis revenue breakdown by geographic segment: 6.5% from Japan , 5.1% from France, 7.5% from Germany, 34.5% from United States and 46.5% from Other
Novartis Online and Social Media Presence
245.4k Twitter followers
Novartis has 245.4k Twitter Followers. The number of followers has increased 0.3% month over month and increased 1.2% quarter over quarter
Novartis News and Updates
Global Eye Infections Treatment Market Size & Positive Long-Term Growth Outlook 2019-2025 : Allergan Inc., Alcon Laboratories Inc., Johnson & Johnson Ltd., Pfizer Inc., Merck & Co., Inc., Novartis
Cell and Gene Therapy Market – Major Technology Giants in Buzz Again | Amgen, Biogen, BioMarin Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis
Biosimilar Drugs Market Growth & Key Business Strategies by Leading Industry Players Novartis, Celltrion, Biocon, Hospira, Merck Serono, Biogen idec, Genentech
Trending Report on Systemic Hypertension Market 2019: By Top Leading Players like Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim, Sanofi, and Pfizer
Congenital Adrenal Hyperplasia Market 2019 Global Analysis By Key Players – Fusion IP plc, Novartis AG, Mitsubishi Chemical Holdings, Johnson & Johnson, GlaxoSmithKline
Novartis CEO lauds Trump administration plan to overhaul rebates
Novartis Company Life and Culture
Novartis Frequently Asked Questions
When was Novartis founded?
Novartis was founded in 1996.
Who are Novartis key executives?
Novartis's key executives are Vasant Narasimhan, Steven Baert and Bertrand Bodson.
How many employees does Novartis have?
Novartis has 126,000 employees.
What is Novartis revenue?
Latest Novartis annual revenue is $49.1 b.
What is Novartis revenue per employee?
Latest Novartis revenue per employee is $389.8 k.
Who are Novartis competitors?
Competitors of Novartis include Urovant Sciences, Teva Pharmaceuticals and Merck.
Where is Novartis headquarters?
Novartis headquarters is located at Forum 1, Novartis Campus, Basel.
Where are Novartis offices?
Novartis has offices in Basel, Surrey, Bangkok, Barcelona and in 33 other locations.
How many offices does Novartis have?
Novartis has 37 offices.